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Hypertonic saline solution reduces the inflammatory
response in endotoxemic rats
Mariana Cardillo Theobaldo, Hermes Vieira Barbeiro, Denise Frediani Barbeiro, Ricardo Petroni, Francisco
Garcia Soriano
Faculdade de Medicina da Universidade de Sa˜o Paulo, Emergency Medicine Division, Sa˜o Paulo/SP, Brazil.
OBJECTIVE: Volume replacement in septic patients improves hemodynamic stability. This effect can reduce the
inflammatory response. The objective of this study was to evaluate the effect of 7.5% hypertonic saline solution
versus 0.9% normal saline solution for volume replacement during an inflammatory response in endotoxemic rats.
METHODS: We measured cytokines (serum and gut), nitrite, and lipid peroxidation (TBARS) as indicators of
oxidative stress in the gut. Rats were divided into four groups: control group (C) that did not receive
lipopolysaccharide; lipopolysaccharide injection without treatment (LPS); lipopolysaccharide injection with saline
treatment (LPS +S); and lipopolysaccharide injection with hypertonic saline treatment (LPS +H). Serum and intestine
were collected. Measurements were taken at 1.5, 8, and 24 h after lipopolysaccharide administration.
RESULTS: Of the four groups, the LPS +H group had the highest survival rate. Hypertonic saline solution treatment
led to lower levels of IL-6, IL-10, nitric oxide, and thiobarbituric acid reactive substances compared to 0.9% normal
saline. In addition, hypertonic saline treatment resulted in a lower mortality compared to 0.9% normal saline
treatment in endotoxemic rats. Volume replacement reduced levels of inflammatory mediators in the plasma and
gut.
CONCLUSION: Hypertonic saline treatment reduced mortality and lowered levels of inflammatory mediators in
endotoxemic rats. Hypertonic saline also has the advantage of requiring less volume replacement.
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INTRODUCTION
Sepsis syndrome is the leading cause of death for patients
in the intensive care unit (1). The syndrome occurs as a
consequence of inappropriate immune activation due to
bacteria and bacterial components released during infection
(2). Host receptors recognize distinct bacterial components
and initiate the inflammatory response. The bacterial cell
wall component lipopolysaccharide (LPS) is one of the most
potent known inducers of the inflammatory response and
employs Toll-like receptor 4 (TLR4) to exert its effects (3).
The mechanism by which LPS induces endotoxic shock is
related to its capacity to activate the NF-kB family of
transcription factors, which enables the expression of
several critical genes involved in the pathogenesis of septic
shock: TNF-a, interleukins (IL-1b, IL-2, IL-6, and IL-8),
adhesion molecules (I-CAM-1 and E-selectin), cyclooxygen-
ase- 2, and inducible NO synthase (4). It has been shown
that MAPK is functionally associated with the transcription
factor NF-kB. In the absence of MAPK, the in vivo release of
inflammatory mediators is down-regulated because NF-kB
dependent activation is compromised (5). Hypertonic saline
has been shown to reduce the activity of MAPK (6,7). The
exacerbated inflammatory condition can induce cell necro-
sis, leading to organ dysfunction and death (2,3,8). The gut
is one of the most important organs involved in sepsis, and
it is the largest interface between the individual and his/her
environment. An intact intestinal barrier is essential for
good health and the prevention of various diseases. The
intestinal barrier has various immunological and non-
immunological components (4). Lung damage is a frequent
cause of respiratory failure and implies the use of mechan-
ical ventilation, which is also associated with a high risk of
death in septic patients (4).
The beneficial effects of hypertonic saline were first
shown by Velasco et al. in an experiment on hemorrhagic
shock (9). Hypertonic saline limits local and end-organ
injury in experimental pancreatitis and reduces mortality (9)
by altering circulating plasma volume, reducing levels of
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trypsinogen, preventing acinar necrosis, and reducing levels
of inflammatory cytokines and pancreatic infection. Our
group showed that hypertonic saline protects the lung (10)
and liver (11) from injury after pancreatitis by modulating
the expression and activity of several proteins (12). Previous
studies in hypovolemic shock and pancreatitis indicated
that infusion of hypertonic saline reduced the production of
pro-inflammatory cytokines and increased the production
of anti-inflammatory cytokines, such as IL-10 (13-17).
Studies using hypertonic saline in the setting of sepsis have
reported hemodynamic improvements, which lead to better
tissue perfusion and reduced necrosis and inflammation. A
recent clinical trial using hypertonic saline (7.5% NaCl)
noted an improvement in cardiac contractility and vascular
tone in patients receiving hypertonic saline compared to
normal saline (18). The aim of the present study was to
assess the impact of hypertonic saline on the systemic
inflammatory response and on the gut in experimental
endotoxemia.
MATERIALS AND METHODS
All procedures were performed according to the Guide
for the Care and Use of Laboratory Animals published by
the US National Institutes of Health. The study protocol
was approved by the Research Ethics Committee of the
University of Sa˜o Paulo, School of Medicine, Hospital das
Clı´nicas.
Endotoxemic induction
Male Wistar rats weighing 253.9¡26.2 g were randomly
assigned to four main groups: 1 - endotoxemic - LPS group
(n = 10), induced by a single intraperitoneal injection of LPS
(10 mg/kg) (extracted from Escherichia coli, serotype 026:B6;
Sigma-Aldrich Canada, Ltd., Oakville, Ontario, Canada); 2 -
endotoxemia treated with a single dose of hypertonic
solution 7.5% (4 ml/kg) (LPS +H); 3 - group treated with a
single dose of saline solution 0.9% (34 ml/kg) (LPS +S); and
4 - control group that did not receive LPS (C). The control
group (C) was used to obtain baseline values. The LPS+S
and LPS+H groups were treated 15 minutes after LPS
injection. Samples of serum and intestine were collected 1.5,
8, and 24 h after LPS injection. The animals were anesthe-
tized with chloral hydrate (20 mg/ml).
Experimental protocols
For biochemical measurements, 90 rats were made endo-
toxemic by LPS injection, and 18 were sham. The measurements
from the plasma and gut were taken 1.5, 8, and 24 h after LPS
injection. Blood samples were obtained by cardiac puncture.
Harvested samples from the gut (ileum) were immediately
frozen in liquid nitrogen. Tissue samples were stored at270 C˚
until they were assayed for cytokines, as detailed below. For
survival experiments, 50 animals were exposed to LPS, and
their mortality was then recorded every 8 h for 24 h.
Measurements
Tissue nitrite. Tissue nitrate and nitrite levels were
measured as an index of NO production. First, nitrate in
the sample was reduced to nitrite by incubation with nitrate
reductase (610 mU/mL) and NADPH (170 mM) at room
temperature for 3 h. After 3 h, the nitrite concentration in the
samples was measured using the Griess reaction by adding
100 mL of Griess reagent (0.1% naphthalethylenediamine
dihydrochloride in water and 1% sulfanilamide in 5%
concentrated H3PO4; 1:1). The optical density at 550 nm
(OD 550, corrected for absorbance at 650 nm) was measured
using a Spectramax microplate reader (Molecular devices,
Minnesota, USA). Nitrite concentrations were calculated
using an OD 550 and a standard solution of sodium nitrite
prepared in phosphate-buffered saline (PBS).
MDA assay
MDA formation was utilized to quantify lipid peroxida-
tion in the tissues and was measured as thiobarbituric acid-
reactive material. Tissues were homogenized (100 mg/mL)
in a 1.15% KCl buffer. Two hundred microliters of the
homogenate was added to a reaction mixture consisting of
1.5 mL of 0.8% thiobarbituric acid, 200 mL of 8.1% sodium
dodecyl sulfate, 1.5 mL of 20% acetic acid (pH 3.5), and 600
mL of distilled water. The mixture was then heated at 90 C˚
for 45 min. After cooling to room temperature, the samples
were cleared by centrifugation (10,000 g for 10 min), and
their absorbances were measured at 532 nm using 1,1,3,3-
tetramethoxypropane as an external standard. The level of
lipid peroxides was expressed as nmol MDA/mg protein
(Bradford assay).
TNF-a, IL-6, and IL-10 — The plasma concentrations and
tissue levels of immunoreactive murine TNF-a (DY410), IL-6
(DY406) and IL-10 (DY417) were determined using com-
mercially available enzyme-linked immunoabsorbent assays
(ELISA) according to the manufacturer’s protocol (R&D
Systems, Minneapolis, MN).
Tissue preparation
Frozen tissue (100 mg) was pulverized in liquid nitrogen.
Samples were homogenized in NP40 buffer containing
135 mM NaCl, 20 mM Tris (pH 8.0), 10% glycerol, and
proteolytic enzyme inhibitors (40 ug/mL phenylmethylsu-
fonylfluoride 1 mM; Sigma, St, Louis, MO). After separating
the debris by centrifugation for 30 min at 10,000 rpm, the
supernatants were preserved, and the protein concentra-
tions were calculated using the Bradford method (Bio Rad,
Hercules, CA). Samples were stored at –80 C˚ until assayed.
Statistical analysis
All values were expressed as means ¡ standard errors
of the mean (SEM). The analyses were performed using
InStat Statistical Software (GraphPad, La Jolla, CA, USA).
Comparisons between the experimental groups were per-
formed using analysis of variance. A Tukey test was used as a
post hoc test to compare individual groups. A p-value less
than 0.05 was considered to be significant. A log-rank test
was used to analyze survival.
RESULTS
The values in the sham group were the same along the
time course of the study. Therefore, we pooled and used
these data as time zero for the control group.
Plasma cytokine concentrations are illustrated in Figure 1.
The time points chosen for this analysis (1.5, 8, and 24 h after
LPS injection) correspond to the peak and relevant time course
of circulating cytokine levels in this model. LPS induced an
increase in plasma levels of TNF-a, IL-6, and IL-10 compared
to the control group. Plasma levels of TNF-a did not change
following administration of normal saline or hypertonic saline
during the entire study. However, treatment with hypertonic
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saline did induce a significant decrease in plasma levels of
the pro-inflammatory cytokine IL-6 (from 11.58¡1.07 ng/ml
to 1.84¡0.91 ng/ml at 1.5 h), and the anti-inflammatory
cytokine IL-10 (from 475.08¡106.80 pg/ml to 65.89¡
10.31 ng/ml).
The cytokine levels in the gut are illustrated in Figure 2.
LPS induced high levels of all measured cytokines compared
to the control group. Volume infusion was characterized by
lower tissue levels of cytokines compared to the LPS group.
Hypertonic saline treatment led to an increase in TNF-a
levels in the first time period measured compared to the LPS
group. However, at 24 h, hypertonic saline was effective in
reducing TNF-a levels compared to the LPS and the LPS+S
groups (TNF-a, from 3.72¡0.33 pg/mg to 2.48¡0.40 pg/mg
at 24 h). Hypertonic saline treatment reduced IL-6 (from
94.44¡33.01 pg/mg to 53.97¡8.51 pg/mg at 1.5 h) and IL-
10 (from 6.57¡0.76 pg/mg to 2.42¡0.68 pg/mg at 8 h)
levels more than the LPS group.
Alterations in the gut due to oxidative stress were further
investigated by measuring malondialdehyde (MDA) formation
(Figure 3) and nitric oxide (NOx) (Figure 4) levels. Hypertonic
saline treatment reduced the levels of MDA in the gut.
Hypertonic saline significantly reduced MDA levels compared
to normal saline at 24 h (from 14.05¡¡1.40 nmol/mg to
2.12¡0.48 nmol/mg at 24 h), despite having lower levels of
MDA at baseline. For nitric oxide only, hypertonic saline
treatment as associated with significant reduction at 1.5 h (NOx,
from 33.35¡9.95 mmol/mg to 7.97¡2.60 mmol/ml at 1.5 h).
Based on these data on MDA and nitric oxide, hypertonic saline
reduced the negative impact of oxidative stress on the gut.
The results of the survival experiments are shown in
Figure 5. Rats in the LPS group started to die at 8 h. Rats
that received normal saline (Figure 5) started to die 16 h
after LPS administration, with a mortality rate approaching
40% at 24 h post-LPS. The mortality rate at the end of the
experiment was similar between the normal saline group
and the LPS group. Rats that received hypertonic saline
started to die at 16 h and had a mortality rate of 15%. The
onset of death was markedly delayed in rats receiving
volume treatment. Rats treated with hypertonic saline had a
statistically significant survival advantage on the log-rank
test.
Figure 1 - Inflammatory profile - Cytokine concentrations (pg/ml) in
serum: TNF-a (a), IL-10 (b), and IL-6 (c). Wistar male rats were
challengedwith LPS (LPS - white) and treatedwith SH (LPS+H - black)
and SS (LPS+S - gray). The levels of TNF- a, IL-10 and IL-6 were
measured at 1.5, 8 and 24 h after the administration of LPS in serum.
*p,0.05 when compared to the LPS group in the same period.
#p,0.05 when compared to the LPS+S group in the same period.
Data are means¡SEM.
Figure 2 - Inflammatory profile - Cytokine concentrations (pg/ml)
in gut: TNF-a (a), IL-10 (b), and IL-6 (c). Wistar male rats were
challenged with LPS (LPS - white) and treated with SH (LPS+H -
black) and SS (LPS+S - gray). The levels of TNF- a, IL-10 and IL-6
were measured at 1.5, 8, and 24 h after the administration of LPS
in the gut. *p,0.05 when compared to the LPS group in the
same period.#p,0.05 when compared to the LPS+S group in the
same period. Data are means¡SEM.
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DISCUSSION
In this article, we investigated the effects of hypertonic
saline in an experimental endotoxemic model. Hypertonic
saline-treated animals had reduced levels of TNF, IL-6, IL-
10, nitric oxide and superoxide in the plasma and gut. In
addition, we showed that hypertonic saline treatment
resulted in a higher survival rate compared to no treatment
or normal saline treatment. Previous data from our
laboratory and other investigators indicate that hypertonic
saline has in vivo and in vitro anti-inflammatory effects.
These effects are thought to be mediated, at least in part, by
MAPK. It is also suggested that hypertonic saline acts
mostly through cytoskeleton changes (14,19). The data
presented in our study confirm and expand on these
previous findings by showing that hypertonic saline has
major beneficial effects in a model of endotoxemia.
Effects of hypertonic saline on the production of
cytokines during endotoxemia
LPS induced a massive systemic inflammatory response,
evidenced by the high levels of tissue and plasma TNF-a and
IL-6. Because both TNF-a and IL-6 are proximal mediators of
septic shock, it is likely that their downregulation was a
central mechanism underlying the overall beneficial effects of
hypertonic saline. In general, it is presumed that these
mediators exert detrimental effects when extremely high
levels are present. However, it has been proposed that
complete inhibition of these cytokines in sepsis is detrimental
because an appropriate level of cytokines is necessary for
fighting bacteria (20). Hypertonic saline was able to reduce
proinflammatory cytokine levels but did not completely
inhibit cytokine activity. This outcome enabled an appro-
priate amount of physiologic cytokine activity.
Another feature of the LPS group was the high tissue and
plasma levels of the anti-inflammatory cytokine IL-10. IL-10
levels were also reduced by hypertonic saline infusion. In
addition, IL-10 has been shown to be crucial in preventing the
overproduction of proinflammatory cytokines during sys-
temic inflammation (21). However, this outcome did not occur
in our study. Hypertonic saline decreased IL-10 and consis-
tently reduced inflammation after LPS administration. These
findings are consistent with previous studies that report the
deleterious effects of increased IL-10 production in animal
models of septic shock. Indeed, IL-10 was reported to suppress
lymphocyte proliferation and lymphokine production during
sepsis, and the administration of anti-IL-10 monoclonal
antibodies has been shown to improve the survival of mice
after Cecal Ligation and Puncture (CLP) (22) and in a two-hit
model of EQ CLP followed by intratracheal instillation of
Pseudomonas (23). The adequate levels and balance between
proinflammatory and anti-inflammatory cytokines can reduce
self-damage and maintain enough activity against bacteria to
protect animals from exaggerated inflammation, bacterial
proliferation, and invasion (20). In addition, it has been
proposed that PMN activation and recruitment to various
organs (especially the lung) were triggered by factors
contained in mesenteric lymph tissue (24), which suggests a
critical link between gut dysfunction, PMN activation, and
distant organ injury in shock.
Effects of hypertonic saline on the production of
nitric oxide and oxidative stress during
endotoxemia
Reactive oxygen species and reactive nitrogen species are
produced during the inflammatory process of sepsis and
Figure 3 - Oxidative stress - MDA concentrations (nmol/mg of
protein) in the intestine. Wistar male rats were challenged with LPS
(LPS - white); 15 minutes later, they were treated with SH (LPS+H -
black) and SS (LPS+S - gray). The levels ofMDAweremeasured in the
intestine. *p,0.05 vs. LPS in the same period; & p,0.05 vs. LPS and
HS in the same period. n=10mice per group. Data aremeans¡SEM.
Figure 4 -Oxidative stress -Nitrite concentrations (mmol/mgof protein)
in the intestine. Wistar male rats were challenged with LPS (LPS -
white) and treated with SH (LPS+H - black) and SS (LPS+S - gray). The
levels of nitrite weremeasured in the intestine. *p,0.05 vs. LPS in the
same period. n=10 mice per group. Data are means¡SEM.
Figure 5 - Survival curve - The effect of treatment with SH or SS
on the mortality of the endotoxemic rat challenged with
intraperitoneal LPS (10 mg/kg) 15 min before the treatment.
LPS+H group treated with SH; LPS+S treated with SS; LPS without
treatment. n =10 mice per group.
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endotoxemia (3,8,25). The high affinity between NO and O2-
leads to the rapid production of peroxynitrite (ONOO-),
which forms acidic peroxynitrous (ONOOH). Peroxynitrous
is an unstable chemical species that decomposes into two
free radicals: nitrite (NO2-) and hydroxyl radical (OH-) (25).
This oxidant scenario can induce important organ
damage, causing dysfunction (26,27). Volume replacement
reduced nitric oxide production in our study. Hypertonic
saline resulted in significant nitric oxide reduction early
after the onset of endotoxemia. Despite the advantages of
hypertonic saline, this protective effect is not exclusive of
hypertonic saline and can be related to the hemodynamic
improvement produced by volume infusion. However, the
data on lipid peroxidation indicated a more intense
reduction with hypertonic treatment compared to normal
saline, and this effect lasted for the entire study period.
Effects of hypertonic saline on survival after
endotoxemia
We found that hypertonic saline significantly improved
the survival of endotoxemic rats. The effects of hypertonic
saline were observed in a post-treatment strategy. Although
both types of volume replacement were effective in
modulating the inflammatory response, the group treated
with hypertonic saline had a better oxidant profile and
improved survival rate. Altogether, these data indicate that
hypertonic saline may represent a valuable approach for
reducing systemic inflammation, reducing oxidative stress
and improving outcomes in clinical endotoxemic shock.
Several distinct strategies have been previously reported to
improve survival in animals challenged with endotoxemia
or sepsis. The steroid hormone dehydroepiandrosterone
reduced short-term mortality, an effect associated with a
reduction of TNF-a release and an improvement in the
activity of T cell immunity (28). Finally, neutralization of
macrophage migration inhibitory factor (MIF) by anti-MIF
antibodies was shown to produce a marked increase in
survival, even when the treatment was delayed up to 8 h
after CLP. This study defined the critical role of MIF in the
pathogenesis of septic shock (29). Although it is difficult to
compare the results of the aforementioned studies with our
data, it is worth mentioning that hypertonic saline was
effective in our severe model of LPS-induced shock. The
LPS dose used in this study killed almost 35% of the control
group. Our study provides evidence that hypertonic saline,
beyond its immune-modulatory effects, also affords protec-
tion from several important pathophysiologic alterations
associated with endotoxemia, such as oxidant stress.
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